Related Experiment Videos
Cyclosporine in dermatology.
A K Gupta1, M D Brown, C N Ellis
1Department of Dermatology, University of Michigan Medical Center, Ann Arbor 48109-0314.
Journal of the American Academy of Dermatology
|December 1, 1989
Summary
Oral cyclosporine effectively treats certain skin conditions by targeting helper T cells. While generally safe short-term at low doses, potential side effects like kidney issues and high blood pressure necessitate careful medical supervision.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- Cyclosporine is a potent immunosuppressant targeting helper T cells.
- Initially used for organ transplant rejection, its efficacy extends to other disorders.
- Helper T cells are implicated in the pathogenesis of cutaneous diseases responsive to cyclosporine.
Purpose of the Study:
- To review cutaneous diseases treated with cyclosporine.
- To discuss cyclosporine's pharmacology and adverse effects in dermatology.
- To evaluate the risk-benefit ratio and need for further research.
Main Methods:
- Review of existing literature on cyclosporine use in dermatology.
- Analysis of pharmacological properties and side effect profiles.
- Assessment of clinical data regarding efficacy and safety.
Main Results:
- Cyclosporine shows efficacy in various dermatoses, linked to its T-cell inhibitory effects.
- Adverse effects include reversible renal dysfunction and hypertension with short-term, low-dose use.
- Lymphoma risk is low in healthy patients on limited, low-dose cyclosporine therapy.
Conclusions:
- Cyclosporine use in dermatology requires careful risk-benefit assessment and medical supervision.
- Limited experience necessitates use within formal clinical studies with established protocols.
- Further controlled studies are needed to confirm efficacy and long-term safety in dermatological conditions.